Startups

Vice President, Global Environmental Health & Safety

Revolution Medicines · Redwood City, California, United States · On-site

← All jobs
About Revolution Medicines

Backed by GV.

About the role

The Vice President, Global Environmental Health & Safety (EHS) is RevMed’s senior enterprise leader accountable for defining and executing the company’s global EHS strategy. This executive will establish the governance, operating model, talent, and management systems required to protect employees, patients, communities, and business continuity across a growing global pharmaceutical enterprise.

What they're looking for

  • BS/BA degree in Environmental Health & Safety, industrial hygiene, occupational safety, environmental science, engineering, life sciences, or a related discipline, an advanced degree is preferred
  • At least 18 years of progressively responsible EHS experience, including significant executive-level leadership in the global pharmaceutical industry
  • At least 10 years of people-leadership experience, with demonstrated success building, scaling, and leading global or regional EHS teams across a complex, matrixed organization
  • Demonstrated experience supporting a broad pharmaceutical operating model, including research laboratories, clinical development, technical operations, external manufacturing, supply chain, corporate offices, and commercial or medical field organizations
  • Demonstrated experience opening and integrating international offices or facilities, establishing EHS programs in new countries, and translating enterprise standards into locally compliant requirements
  • Demonstrated experience managing EHS for a worldwide, mobile, and field-based workforce, including global sales, medical affairs, market access, or comparable commercial organizations
More about this role

Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.

Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.

The Vice President, Global Environmental Health & Safety (EHS) is RevMed’s senior enterprise leader accountable for defining and executing the company’s global EHS strategy. This executive will establish the governance, operating model, talent, and management systems required to protect employees, patients, communities, and business continuity across a growing global pharmaceutical enterprise....

Read the full posting on Revolution Medicines's site ↗

EH&S

Build your edge while you search

Free tools for founders and investors, plus VC Unfiltered, our take on startups, venture and the people who build them.